HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zinc supplementation in critically ill patients: a key pharmaconutrient?

Abstract
The purpose of the present paper is to provide a rationale for zinc supplementation as a potential therapeutic agent in critically ill patients by describing its role in health and disease, conducting a systematic review of current randomized trials in critical care, considering optimum route and dose of administration, and making recommendations for future research. Normal zinc homeostasis is required for a functional immune system, adequate antioxidant capacity, glucose homeostasis, and wound healing. In addition, zinc is a required cofactor for many enzymes, transcription factors, and replication factors. In non-critically ill patients, zinc supplementation has been associated with an improvement in markers of immune function. In critically ill patients, only 4 randomized trials have examined the effect of zinc supplementation on clinical outcomes. When all 4 studies were aggregated, zinc supplementation was associated with a nonsignificant reduction in mortality (relative risk = 0.63, 95% confidence intervals 0.25-1.59, P = .33) and length of stay in intensive care (-0.35 days, -0.85 to 0.15; P = .17). Thus, because of the paucity of clinical data, there is inadequate evidence to recommend the routine use of high-dose zinc supplementation in the critically ill. A first step would be to determine the optimal dose that has a maximal positive effect on underlying inflammatory, immunologic, and metabolic processes yet is safe and tolerated by critically ill patients. Subsequently, large, rigorously designed, randomized trials are required to elucidate the efficacy of such doses of zinc supplementation in this patient population.
AuthorsDaren K Heyland, Naomi Jones, Natalie Z Cvijanovich, Hector Wong
JournalJPEN. Journal of parenteral and enteral nutrition (JPEN J Parenter Enteral Nutr) 2008 Sep-Oct Vol. 32 Issue 5 Pg. 509-19 ISSN: 0148-6071 [Print] United States
PMID18669902 (Publication Type: Journal Article, Meta-Analysis, Review, Systematic Review)
Chemical References
  • Antioxidants
  • Blood Glucose
  • Glutamine
  • Zinc
Topics
  • Antioxidants (physiology, therapeutic use)
  • Blood Glucose (metabolism)
  • Critical Illness (therapy)
  • Dietary Supplements
  • Enteral Nutrition (methods)
  • Glutamine (therapeutic use)
  • Humans
  • Oxidative Stress (drug effects)
  • Randomized Controlled Trials as Topic
  • Wound Healing (physiology)
  • Zinc (deficiency, physiology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: